T-SPOT.TB Assay Testing

Background
The Department of Veterans Affairs, VISN 16, Network Contracting Activity, G.V. (Sonny) Montgomery VA Medical Center is seeking a reference laboratory to perform T-Spot TB Testing. This initiative is crucial due to the potential risk of tuberculosis (TB) transmission in healthcare settings, necessitating effective TB screening measures for VA healthcare employees and patients.

Work Details
The contractor shall provide T-Spot reference laboratory services to the G.V. (Sonny) Montgomery VAMC, Pathology and Laboratory Medicine Service Department. The contractor must have Clinical Laboratory Improvement Acts (CLIA) and College of American Pathologists (CAP) accreditation and will need to maintain good standing status throughout the contract.

Key deliverables include:
1. Test results with a turnaround time within 72 hours of sample submission.
2. Daily specimen pick-up services from Monday through Friday (excluding holidays).
3. Provision of CLIA and CAP accreditation/certification.
4. Inclusion of a VA Identification Card Number (VA ICN) or VA Electronic Data Interchange Personal Identifier (VA EDIPI) number with patient reports for results returned to VA laboratories running VistA Lab.

Period of Performance
Base period from October 1, 2026, through September 30, 2027; Option 1 from October 1, 2027, through September 30, 2028.

Place of Performance
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS.

Bidder Requirements
Bidders must possess CLIA and CAP accreditation and provide documentation confirming their in-house performance of the T-SPOT.TB assay. They should also demonstrate logistics capabilities for daily specimen pickup from the G.V. (Sonny) Montgomery VAMC.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity appears to have a confirmed incumbent based on prior T-SPOT TB testing work performed for the same VA organization, with Quest Diagnostics awarded contract 36C25626P0027 valued at $77,733 for 10/01/25–09/30/26. The current requirement for CLIA/CAP-accredited reference laboratory services and T-Spot TB assay testing with similar specimen logistics and reporting requirements aligns closely with the prior “T-SPOT TB TESTING” scope, and Quest Diagnostics also previously supported related T-SPOT TB testing under IDV 36C25620D0064 (Oxford Immunotec T-SPOT TB TESTING) from 08/01/20–07/31/25.